Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$55.7 - $145.79 $286,910 - $750,964
-5,151 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$135.05 - $182.59 $429,594 - $580,818
3,181 Added 161.47%
5,151 $767,000
Q3 2021

Nov 15, 2021

BUY
$145.58 - $192.14 $286,792 - $378,515
1,970 New
1,970 $287,000
Q1 2021

May 17, 2021

SELL
$140.25 - $196.86 $336,039 - $471,676
-2,396 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$126.47 - $163.7 $8.61 Million - $11.1 Million
-68,102 Reduced 96.6%
2,396 $339,000
Q3 2020

Nov 16, 2020

BUY
$87.44 - $125.0 $6.16 Million - $8.81 Million
70,498 New
70,498 $8.79 Million
Q4 2019

Feb 14, 2020

SELL
$46.07 - $79.54 $359,346 - $620,412
-7,800 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$49.99 - $62.0 $389,922 - $483,600
7,800 New
7,800 $393,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.